T-1249 development hits a snag.
D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D017277:Drug Approval / Q000331:legislation & jurisprudence; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
D019380:Anti-HIV Agents